-
Medical journals
- Career
Clinical Oncology - Issue 6/2024
Editorial
403
Reviews
408Diagnostic-therapeutic management of pulmonary nodulesV. Červeňák, Z. Chovanec, A. Berková, J. Resler, T. Hanslík, M. Kelblová, K. Novosádová, V. Weiss, O. Bílek, J. Vaníček
420Autoimmune pancreatitis as a risk factor of pancreatic cancerD. Solil, P. Dítě, B. Kianička, M. Bojková, M. Uvírová, M. Přecechtělová, J. Dolina
Original Articles
427The treatment combination of obinutuzumab, bendamustine and dexamethasone achieved a deeper response than the previous line of treatment in five patients with Waldenström‘s macroglobulinemiaZ. Adam, L. Pour, M. Krejčí, V. Sandecká, M. Štork, I. Boichuk, Z. Král
433Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018– 2022O. Bílek, I.- Selingerová, M. Kysela, V. Jedlička, T. Kazda, J. Berkovcová, P. Turčáni, A. Poprach, I. Kiss, M. Svoboda, L. Zdražilová-Dubská
Case Reports
451Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström’s macroglobulinemiaZ. Adam, M. Krejčí, L. Pour, B. Weinbergerová, V. Sandecká, M. Štork, I. Boichuk, Z. Řehák, M. Keřkovský, R. Koukalová, L. Zdražilová-Dubská, B. Čechová, Z. Král
463An atypical presentation of bronchogenic cystH. Matsumoto, S. Hasegawa, Y. Maezawa, S. Okauchi, G. Ohara, K. Iguchi, H. Kawai, N. Takayashiki, H. Satoh
Clinical Oncology
2024 Issue 6
Most read in this issue- Diagnostic-therapeutic management of pulmonary nodules
- Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström’s macroglobulinemia
- Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018– 2022
- The treatment combination of obinutuzumab, bendamustine and dexamethasone achieved a deeper response than the previous line of treatment in five patients with Waldenström‘s macroglobulinemia
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career